NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $233,945 | -52.1% | 3,890 | -41.6% | 0.17% | -54.9% |
| Q4 2022 | $488,511 | -3.5% | 6,660 | 0.0% | 0.38% | -9.5% |
| Q3 2022 | $506,000 | +12.7% | 6,660 | +3.1% | 0.42% | +15.7% |
| Q2 2022 | $449,000 | -14.1% | 6,460 | +2.4% | 0.36% | +5.2% |
| Q1 2022 | $523,000 | +21.1% | 6,310 | +9.6% | 0.34% | +28.4% |
| Q4 2021 | $432,000 | -35.4% | 5,755 | 0.0% | 0.27% | -39.8% |
| Q3 2021 | $669,000 | -49.4% | 5,755 | -3.4% | 0.44% | -48.7% |
| Q2 2021 | $1,321,000 | – | 5,955 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |